Guardian Pharmacy Services, Inc.GRDNEarnings & Financial Report
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Revenue
$314.4M
Gross Profit
$60.9M
Operating Profit
$-104.6M
Net Profit
$-122.0M
Gross Margin
19.4%
Operating Margin
-33.3%
Net Margin
-38.8%
YoY Growth
N/A
Guardian Pharmacy Services, Inc. Q3 FY2024 Financial Summary
Guardian Pharmacy Services, Inc. reported revenue of $314.4M for Q3 FY2024, with a net profit of $-122.0M (-38.8% margin). Cost of goods sold was $253.5M, operating expenses totaled $165.5M.
Key Financial Metrics
| Total Revenue | $314.4M |
|---|---|
| Net Profit | $-122.0M |
| Gross Margin | 19.4% |
| Operating Margin | -33.3% |
| Report Period | Q3 FY2024 |
Guardian Pharmacy Services, Inc. Annual Revenue by Year
Guardian Pharmacy Services, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.4B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.4B |
Guardian Pharmacy Services, Inc. Quarterly Revenue & Net Profit History
Guardian Pharmacy Services, Inc. results over the last 6 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $336.6M | +2.2% | $13.5M | 4.0% |
| Q4 FY2025 | $397.6M | — | $20.9M | 5.3% |
| Q3 FY2025 | $377.4M | +20.0% | $9.8M | 2.6% |
| Q2 FY2025 | $344.3M | — | $9.0M | 2.6% |
| Q1 FY2025 | $329.3M | — | $9.4M | 2.9% |
| Q3 FY2024 | $314.4M | — | $-122.0M | -38.8% |
Income Statement
| Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $314.4M | $329.3M | $344.3M | $377.4M | $397.6M | $336.6M |
| YoY Growth | N/A | N/A | N/A | 20.0% | N/A | 2.2% |
Balance Sheet
| Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|
| Assets | $348.0M | $334.0M | $356.3M | $390.0M | $412.7M | $426.9M |
| Liabilities | $214.1M | $170.8M | $176.7M | $194.5M | $194.7M | $194.5M |
| Equity | $133.9M | $163.2M | $179.7M | $195.5M | $217.9M | $232.4M |
Cash Flow
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|
| Operating CF | $17.6M | $19.9M | $28.2M | $34.6M | $6.1M |